Peter V Rabins

Act Staff Full Time

1974 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Dementia Medicine & Life Sciences
Alzheimer Disease Medicine & Life Sciences
Depression Medicine & Life Sciences
Caregivers Medicine & Life Sciences
Psychiatry Medicine & Life Sciences
Nursing Homes Medicine & Life Sciences
Geriatric Psychiatry Medicine & Life Sciences
Quality of Life Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1974 2018

Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role

Black, B. S., Taylor, H. A., Rabins, P. V. & Karlawish, J. May 1 2018 In : Dementia. 17, 4, p. 494-514 21 p.

Research output: Contribution to journalArticle

dementia
experience
caregiver
family member
content analysis
Behavioral Symptoms
Longitudinal Studies
Comorbidity
Epilepsy
Autism Spectrum Disorder

Depressive symptoms in ophthalmology patients

Rabins, P. V. Sep 1 2016 In : JAMA Ophthalmology. 134, 9, p. 1015 1 p.

Research output: Contribution to journalComment/debate

Ophthalmology
Depression
Health Services
Dementia
Inpatients
Ambulatory Care
Social Welfare

Heterogeneity of treatment response to citalopram for patients with Alzheimer's disease with aggression or agitation: The citad randomized clinical trial

Schneider, L. S., Frangakis, C., Drye, L. T., Devanand, D. P., Marano, C. M., Mintzer, J., Mulsant, B. H., Munro, C. A., Newell, J. A., Pawluczyk, S., Pelton, G., Pollock, B. G., Porsteinsson, A. P., Rabins, P. V., Rein, L., Rosenberg, P. B., Shade, D., Weintraub, D., Yesavage, J. & Lyketsos, C. G. May 1 2016 In : American Journal of Psychiatry. 173, 5, p. 465-472 8 p.

Research output: Contribution to journalArticle

Citalopram
Aggression
Alzheimer Disease
Randomized Controlled Trials
Therapeutics